BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND MYH9, P35579, 4627, ENSG00000100345, DFNA17
23 results:

  • 1. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to myh9.
    Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
    Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. LAMC2 mitigates ER stress by enhancing ER-mitochondria interaction via binding to myh9 and MYH10.
    Tong D; Zhou J; Zhou J; Wang X; Gao B; Rui X; Liu L; Chen Q; Huang C
    Cancer Gene Ther; 2024 Jan; 31(1):43-57. PubMed ID: 37891404
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pan-cancer genetic analysis of disulfidptosis-related gene set.
    Liu H; Tang T
    Cancer Genet; 2023 Nov; 278-279():91-103. PubMed ID: 37879141
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers.
    Alanazi SM; Feroz W; Mishra R; Kilroy MK; Patel H; Yuan L; Storr SJ; Garrett JT
    PLoS One; 2023; 18(5):e0285251. PubMed ID: 37200287
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating myh9-Mediated GSK3β/β-Catenin Signaling.
    Li Q; Luo H; Dai FQ; Wang RT; Fan XQ; Luo YY; Deng MS; Wang Y; Long T; Guo W; Xu B; Xu CX; Jin H
    Adv Sci (Weinh); 2023 Apr; 10(11):e2203573. PubMed ID: 36757050
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development.
    Huang C; Liu J; He L; Wang F; Xiong B; Li Y; Yang X
    Bioengineered; 2021 Dec; 12(2):11738-11755. PubMed ID: 34895039
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing myh9 and activating the Wnt/beta-catenin pathway.
    Li Y; Wang Z; Su P; Liang Y; Li Z; Zhang H; Song X; Han D; Wang X; Liu Y; Yang J; Chen B; Wang L; Zhao W; Yang Q
    Mol Ther; 2022 Jan; 30(1):415-430. PubMed ID: 34450253
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Nodular fasciitis of the breast: clinicopathologic and molecular characterization with identification of novel USP6 fusion partners.
    Cloutier JM; Kunder CA; Charville GW; Hosfield EM; García JJ; Brown RA; Troxell ML; Allison KH; Bean GR
    Mod Pathol; 2021 Oct; 34(10):1865-1875. PubMed ID: 34099872
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Nodular fasciitis of the breast: a clinicopathological and genetic analysis of seven cases].
    Zhang YH; Qiu Y; Zhang Z; Chen HJ; Zhang HY
    Zhonghua Bing Li Xue Za Zhi; 2021 May; 50(5):476-481. PubMed ID: 33915654
    [No Abstract]    [Full Text] [Related]  

  • 10. MicroRNA-214-3p targets the PLAGL2-myh9 axis to suppress tumor proliferation and metastasis in human colorectal cancer.
    Zhou Z; Wu L; Liu Z; Zhang X; Han S; Zhao N; Bao H; Yuan W; Chen J; Ji J; Shu X
    Aging (Albany NY); 2020 May; 12(10):9633-9657. PubMed ID: 32413870
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Whole-exome sequencing reveals known and novel variants in a cohort of intracranial vertebral-basilar artery dissection (IVAD).
    Wang K; Zhao S; Zhang Q; Yuan J; Liu J; Ding X; Song X; Lin J; Du R; Zhou Y; Sugimoto M; Chen W; Yuan B; Liu J; Yan Z; Liu B; Zhang Y; Li X; Niu Y; Long B; Shen Y; Zhang S; Abe K; Su J; Wu Z; Wu N; Liu P; Yang X;
    J Hum Genet; 2018 Nov; 63(11):1119-1128. PubMed ID: 30115950
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
    Liang X; Vacher S; Boulai A; Bernard V; Baulande S; Bohec M; Bièche I; Lerebours F; Callens C
    Breast Cancer Res; 2018 Aug; 20(1):88. PubMed ID: 30086764
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma.
    Kas SM; de Ruiter JR; Schipper K; Annunziato S; Schut E; Klarenbeek S; Drenth AP; van der Burg E; Klijn C; Ten Hoeve JJ; Adams DJ; Koudijs MJ; Wesseling J; Nethe M; Wessels LFA; Jonkers J
    Nat Genet; 2017 Aug; 49(8):1219-1230. PubMed ID: 28650484
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Screening for Del 185 AG and 4627C>A BRCA1 Mutations in breast cancer Patients from Lahore, Pakistan.
    Aziz F; Fatima W; Mahmood S; Khokher S
    Asian Pac J Cancer Prev; 2016; 17(4):1725-7. PubMed ID: 27221844
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Transcriptional factors p300 and MRTF-A synergistically enhance the expression of migration-related genes in MCF-7 breast cancer cells.
    He H; Wang D; Yao H; Wei Z; Lai Y; Hu J; Liu X; Wang Y; Zhou H; Wang N; Luo XG; Zhang TC
    Biochem Biophys Res Commun; 2015 Nov; 467(4):813-20. PubMed ID: 26476216
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: interaction with IQ motif-containing factors.
    Robinson TJ; Pai M; Liu JC; Vizeacoumar F; Sun T; Egan SE; Datti A; Huang J; Zacksenhaus E
    Cell Cycle; 2013 Sep; 12(18):3013-24. PubMed ID: 23974104
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Whole-genome analysis informs breast cancer response to aromatase inhibition.
    Ellis MJ; Ding L; Shen D; Luo J; Suman VJ; Wallis JW; Van Tine BA; Hoog J; Goiffon RJ; Goldstein TC; Ng S; Lin L; Crowder R; Snider J; Ballman K; Weber J; Chen K; Koboldt DC; Kandoth C; Schierding WS; McMichael JF; Miller CA; Lu C; Harris CC; McLellan MD; Wendl MC; DeSchryver K; Allred DC; Esserman L; Unzeitig G; Margenthaler J; Babiera GV; Marcom PK; Guenther JM; Leitch M; Hunt K; Olson J; Tao Y; Maher CA; Fulton LL; Fulton RS; Harrison M; Oberkfell B; Du F; Demeter R; Vickery TL; Elhammali A; Piwnica-Worms H; McDonald S; Watson M; Dooling DJ; Ota D; Chang LW; Bose R; Ley TJ; Piwnica-Worms D; Stuart JM; Wilson RK; Mardis ER
    Nature; 2012 Jun; 486(7403):353-60. PubMed ID: 22722193
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The role of non-muscle myosin IIA in aggregation and invasion of human MCF-7 breast cancer cells.
    Derycke L; Stove C; Vercoutter-Edouart AS; De Wever O; Dollé L; Colpaert N; Depypere H; Michalski JC; Bracke M
    Int J Dev Biol; 2011; 55(7-9):835-40. PubMed ID: 22161839
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL.
    Leong S; McKay MJ; Christopherson RI; Baxter RC
    J Proteome Res; 2012 Feb; 11(2):1240-50. PubMed ID: 22133146
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis.
    Medjkane S; Perez-Sanchez C; Gaggioli C; Sahai E; Treisman R
    Nat Cell Biol; 2009 Mar; 11(3):257-68. PubMed ID: 19198601
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.